BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer ; volume:16 ; number:1 ; day:27 ; month:11 ; year:2024 ; pages:1-10 ; date:12.2024
Clinical epigenetics ; 16, Heft 1 (27.11.2024), 1-10, 12.2024
- Creator
-
Fiegl, Heidelinde
Schnaiter, Simon
Reimer, Daniel U.
Leitner, Katharina
Nardelli, Petra
Tsibulak, Irina
Wieser, Verena
Wimmer, Katharina
Schamschula, Esther
Marth, Christian
Zeimet, Alain G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-024-01781-0
- URN
-
urn:nbn:de:101:1-2502122201316.182785101053
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fiegl, Heidelinde
- Schnaiter, Simon
- Reimer, Daniel U.
- Leitner, Katharina
- Nardelli, Petra
- Tsibulak, Irina
- Wieser, Verena
- Wimmer, Katharina
- Schamschula, Esther
- Marth, Christian
- Zeimet, Alain G.
- SpringerLink (Online service)
Other Objects (12)
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
BRCA-assoziierter Brustkrebs : erblicher Brustkrebs: was Sie über die BRCA Muttaion wissen müssen
BRCA 1 and Ct IP promote alternative non‐homologous end‐joining at uncapped telomeres
BRCA Testing in Serbia and Montenegro
Die Patentierung von Krankheitsgenen : dargestellt am Beispiel der Patentierung der Brustkrebsgene BRCA 1 und BRCA 2
Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells
Effekte eines hochintensiven Kraft-/ Ausdauertrainings (HIRT/HIT) auf die BRCA1-Genexpression im Muskel und die BRCA1-Proteinbiosynthese von BRCA-Mutationsträgern
Trends in BRCA testing and socioeconomic deprivation
Emerging strategies in BRCA-positive pancreatic cancer
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
Thwarting endogenous stress: BRCA protects against aldehyde toxicity
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
BRCA-assoziierter Brustkrebs : erblicher Brustkrebs: was Sie über die BRCA Muttaion wissen müssen
BRCA 1 and Ct IP promote alternative non‐homologous end‐joining at uncapped telomeres
BRCA Testing in Serbia and Montenegro
Die Patentierung von Krankheitsgenen : dargestellt am Beispiel der Patentierung der Brustkrebsgene BRCA 1 und BRCA 2
Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells
Effekte eines hochintensiven Kraft-/ Ausdauertrainings (HIRT/HIT) auf die BRCA1-Genexpression im Muskel und die BRCA1-Proteinbiosynthese von BRCA-Mutationsträgern
Trends in BRCA testing and socioeconomic deprivation
Emerging strategies in BRCA-positive pancreatic cancer
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
Thwarting endogenous stress: BRCA protects against aldehyde toxicity
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
BRCA-assoziierter Brustkrebs : erblicher Brustkrebs: was Sie über die BRCA Muttaion wissen müssen
BRCA 1 and Ct IP promote alternative non‐homologous end‐joining at uncapped telomeres
BRCA Testing in Serbia and Montenegro
Die Patentierung von Krankheitsgenen : dargestellt am Beispiel der Patentierung der Brustkrebsgene BRCA 1 und BRCA 2
Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells
Effekte eines hochintensiven Kraft-/ Ausdauertrainings (HIRT/HIT) auf die BRCA1-Genexpression im Muskel und die BRCA1-Proteinbiosynthese von BRCA-Mutationsträgern
Trends in BRCA testing and socioeconomic deprivation
Emerging strategies in BRCA-positive pancreatic cancer
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies